| Autor: |
Ha Young Jang, Jung Mi Oh, In-Wha Kim |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Frontiers in Neuroscience, Vol 16 (2022) |
| Druh dokumentu: |
article |
| ISSN: |
1662-453X |
| DOI: |
10.3389/fnins.2022.989174 |
| Popis: |
IntroductionAlzheimer’s disease and other forms of dementia are disease that bring an increased global burden. However, the medicine developed to date remains limited. The purpose of this study is to predict drug repositioning candidates using a computational method that integrates gene expression profiles on Alzheimer’s disease and compound-induced changes in gene expression levels.MethodsGene expression data on Alzheimer’s disease were obtained from the Gene Expression Omnibus (GEO) and we conducted a meta-analysis of their gene expression levels. The reverse scores of compound-induced gene expressions were computed based on the reversal relationship between disease and drug gene expression profiles.ResultsReversal genes and the candidate compounds were identified by the leave-one-out cross-validation procedure. Additionally, the half-maximal inhibitory concentration (IC50) values and the blood-brain barrier (BBB) permeability of candidate compounds were obtained from ChEMBL and PubChem, respectively.ConclusionNew therapeutic target genes and drug candidates against Alzheimer’s disease were identified by means of drug repositioning. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
